failure. In a prospective randomized study in all PM below 1500 g as well as in all P!l aand newborns after intensive care therapy sith max H+ (urine pH < 5.4 on two succeeding days), the influence of oral alkali therapy on the increase of BW was investigated. Group B received 2 mmol NaHC03/kg/d for 7 days; group A (controls) was retrospectively divided into A1 (urine pH < 5.4 on 7 days) and A2 (urine pH t 5.4 for t 1 day The urinary sodium concentration(UNa) and sodiumlpotassium ratio(Na/K)are frequently used to assess sodium status in infants with abnormal scdium losses. However,?irhr urine collection in infants is difficult and prone to error and we therefore studied the validity of using spot urine samples, comparing values for "spot" LJNa and Na/K with 24hr urine collections and 24ht fractional sodium excretion(FeNa). Twenry infants(median age 24 ds,ranged 6-150d;rnean weight 2.6 kr SD 0.65 kg)were studied,all receiving parenteral or enteral nutrition.Plasma levels of sodium, potassium and creatinine were all within the normal range. Urine was collected using a specially designed metabolic cot. Collections were made at 2 and 4hr, and then regularly during the next 20hrs. One ml aliquotes from the 0-2 and 2-4hr urine collections here analysed separately(spot 1 and spot 2);all remaining urine collected was pooled(24hr urine). -UNa in both spot samples correlated positively and significantly with UNa in 24hr urine(rl= 0.67,p<O.01;r2=0.62,p<O.Ol).Furthermore,Na/K in both spot urines correlated with NaIK in 24hr urine(rl=0.76,p<O.OOl;r2=0.78, p<O.OO1) and FeNa(rl=0.47,p<0.05;r?=0.61.p<0.01).
HMG-CoA reductarc a c t i~i r y .~~~-s c c t a t e incorporation inlo cholesterol and cholestcryl ester formation were smdied in fibmblasu from 6 patients with mcvalonic aciduria due lo mcvalonate kinarc deficiency (MK-) in response w different concentrations of LDL and nonlipoprotein cholesterol. Despite a virmally complete deficiency of rnevalonate khaw in cxuacts of fibmblasu derived from the paticnu, mere was still significant acrlvity for the cholesterol biosynlhctic puhway. assessed by monitoring 14~-acelarr incorporation inw cholesterol in intact Rbrablast manolayen. failure. In a prospective randomized study in all PM below 1500 g as well as in all P!l aand newborns after intensive care therapy sith max H+ (urine pH < 5.4 on two succeeding days), the influence of oral alkali therapy on the increase of BW was investigated. Group B received 2 mmol NaHC03/kg/d for 7 days; group A (controls) was retrospectively divided into A1 (urine pH < 5.4 on 7 days) and A2 (urine pH t 5.4 for t 1 day The urinary sodium concentration(UNa) and sodiumlpotassium ratio(Na/K)are frequently used to assess sodium status in infants with abnormal scdium losses. However,?irhr urine collection in infants is difficult and prone to error and we therefore studied the validity of using spot urine samples, comparing values for "spot" LJNa and Na/K with 24hr urine collections and 24ht fractional sodium excretion(FeNa). Twenry infants(median age 24 ds,ranged 6-150d;rnean weight 2.6 kr SD 0.65 kg)were studied,all receiving parenteral or enteral nutrition.Plasma levels of sodium, potassium and creatinine were all within the normal range. Urine was collected using a specially designed metabolic cot. Collections were made at 2 and 4hr, and then regularly during the next 20hrs. One ml aliquotes from the 0-2 and 2-4hr urine collections here analysed separately(spot 1 and spot 2);all remaining urine collected was pooled(24hr urine). -UNa in both spot samples correlated positively and significantly with UNa in 24hr urine(rl= 0.67,p<O.01;r2=0.62,p<O.Ol).Furthermore,Na/K in both spot urines correlated with NaIK in 24hr urine(rl=0.76,p<O.OOl;r2=0.78, p<O.OO1) and FeNa(rl=0.47,p<0.05;r?=0.61.p<0.01).
Conclusion:
The sodium concentration and sodiun/potassium ratio in spot urines accurately reflect values derived from 24hr urine collection and may be used to assess sodium balance in infants. Several studies have demonstrated thethermogeniceffect of ephedrine and methylxanthines. However, no data are available on the thermic effect of these drugs in chi1dren.h the present study we investigated the thermogenic effects of 1 mg/kg lean body mass (LBM) (group I ,n=5) or 2 mg/kg LBM (group 2,n=7) ephedrine and 3 mg/kg LBM (group 3,n=6) or 6 mg/kg LBM (group 4, n=5) aminophylline in 10 obese boys and 13 obese girls.Their age (meantSE), body weight, body fat and LBM were 12.lt0.6 yr,78.4 t 5 . 2 kg, 33.&0.8 % and 48.lt3.3 kg, respectively. Resting metabolic rate (RMR) was measured by Kipp and Zonnen indirect calorimeter after an overnight fast for 45 min and for 180 min zfter the administration of the drugs. RMR rose after the consumption of the drugs by 3.9t0.7 %, 7.5t1.2 %, 10.Et2.2 % and 20.0t2.5 % in group 1,2,3 and 4 , respectively (pC0.05, group 1 vs 3 and 2 vs 4 ) . Heart rate was increased significantly by both drugs. Systolic blocd pressure was elevated only by ephedrine. Conc1usion:The thermogenic effects of ephedrine and aminophylline are dose dependent. Aminophylline is a much more effective thermogenic drug in children than ephedrine and it does not increase blood pressure. Before it could be reconmended as an aid for the treatment of extremely obese children, a chronic energy balance study is needed.
